Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990;38(3):255-8.
doi: 10.1007/BF00315026.

Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients

T Hasegawa  1 , K Takagi, T Kuzuya, M Nadai, R Apichartpichean, I Muraoka
Affiliations

Effect of mequitazine on the pharmacokinetics of theophylline in asthmatic patients

T Hasegawa et al. Eur J Clin Pharmacol. 1990.

Abstract

The effect of an oral anti-allergic drug, mequitazine, on the pharmacokinetics of theophylline has been investigated in seven asthmatic patients. They received chronic theophylline therapy (a sustained-release theophylline tablet 200-400 mg b.d. at 12 h intervals) and coadministered mequitazine 6 mg for 3 weeks. Plasma theophylline concentration-time curves and the urinary excretion of theophylline and its major metabolites before and after coadministration of mequitazine were compared. No significant change in the pharmacokinetic parameters of theophylline or in the urinary recovery of unchanged drug and its metabolites was observed. Thus, mequitazine did not influence the pharmacokinetics of theophylline and it should be safe for coadministration to asthmatic patients on chronic theophylline therapy.

PubMed Disclaimer

References

    1. Clin Pharmacol Ther. 1982 Mar;31(3):358-69 - PubMed
    1. Clin Pharmacol Ther. 1972 May-Jun;13(3):349-60 - PubMed
    1. N Engl J Med. 1973 Sep 20;289(12):600-3 - PubMed
    1. Am J Hosp Pharm. 1981 Aug;38(8):1164-6 - PubMed
    1. Clin Pharmacokinet. 1984 Jul-Aug;9(4):309-34 - PubMed